GSTM2 and metabolic dysfunction-associated steatotic liver disease: Previous studies reported that GSTM2 is highly up-regulated in NAFLD or in an HFD-induced fatty liver mice model (by more than 4-fold)6,7, but the mechanism was not evaluated.